NDC 44087-3322
REBIF REBIDOSE
Interferon Beta-1a
REBIF REBIDOSE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Interferon Beta-1a.
| Product ID | 44087-3322_0b175df7-7507-4d2f-bddf-65f707392420 |
| NDC | 44087-3322 |
| Product Type | Human Prescription Drug |
| Proprietary Name | REBIF REBIDOSE |
| Generic Name | Interferon Beta-1a |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2012-12-21 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103780 |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | INTERFERON BETA-1A |
| Active Ingredient Strength | 22 ug/.5mL |
| Pharm Classes | Interferon-beta [CS],Recombinant Human Interferon beta [EPC],Recombinant Proteins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |